Business Description
Bacil Pharma Ltd
ISIN : INE711D01018
Compare
Compare
Traded in other countries / regions
524516.India IPO Date
1994-05-31Description
Bacil Pharma Ltd is an Indian-based pharmaceutical company operating in a single segment. It is engaged in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products. The company manufactures, exports, supplies, and retail Anti Anxiety Medicine, Antihistamines, Chemical Compound, Drugs and Herbal Tablets, and Capsules.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -1.58 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37.8 | |||||
| 3-Year EPS without NRI Growth Rate | -32.7 | |||||
| 3-Year FCF Growth Rate | 80.6 | |||||
| 3-Year Book Growth Rate | -4.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.3 | |||||
| 9-Day RSI | 58.08 | |||||
| 14-Day RSI | 63.47 | |||||
| 6-1 Month Momentum % | 80.95 | |||||
| 12-1 Month Momentum % | 576.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.86 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 27.86 | |||||
| ROA % | 25.83 | |||||
| ROIC % | -16.72 | |||||
| ROC (Joel Greenblatt) % | -543.81 | |||||
| ROCE % | -7.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.45 | |||||
| PE Ratio without NRI | 69.45 | |||||
| PEG Ratio | 2.91 | |||||
| PB Ratio | 15.73 | |||||
| Price-to-Tangible-Book | 15.73 | |||||
| EV-to-EBIT | -252.51 | |||||
| EV-to-EBITDA | -256.89 | |||||
| EV-to-FCF | -9017.55 | |||||
| Price-to-Graham-Number | 6.97 | |||||
| Earnings Yield (Greenblatt) % | -0.39 | |||||
| FCF Yield % | -0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bacil Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | |||
| EPS (TTM) (₹) | 0.65 | ||
| Beta | 0.5 | ||
| Volatility % | 103.16 | ||
| 14-Day RSI | 63.47 | ||
| 14-Day ATR (₹) | 0.925658 | ||
| 20-Day SMA (₹) | 45.9895 | ||
| 12-1 Month Momentum % | 576.74 | ||
| 52-Week Range (₹) | 4.71 - 50.02 | ||
| Shares Outstanding (Mil) | 5.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bacil Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bacil Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bacil Pharma Ltd Frequently Asked Questions
What is Bacil Pharma Ltd(BOM:524516)'s stock price today?
The current price of BOM:524516 is ₹45.15. The 52 week high of BOM:524516 is ₹50.02 and 52 week low is ₹4.71.
When is next earnings date of Bacil Pharma Ltd(BOM:524516)?
The next earnings date of Bacil Pharma Ltd(BOM:524516) is .
Does Bacil Pharma Ltd(BOM:524516) pay dividends? If so, how much?
Bacil Pharma Ltd(BOM:524516) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers